Takeda, Dr Reddy’s to launch dengue vaccine QDENGA in India by 2027
Takeda and Dr Reddy’s have partnered to bring India’s first approved dengue vaccine, QDENGA, to the private market. Dr Reddy’s will distribute the vaccine for pediatric and adult use, with availability expected in the first half of 2027. Takeda Pharmaceutical Company Limited, through its Indian subsidiary Takeda Biopharmaceuticals India Private Limited (together referred to as … Read more